Category: Company cases

Company cases

The year towards growth capital

After the 2022 annual report and extraordinary general meeting, Ekobot is ready for the partially underwritten rights issue, providing capital for delivery of orders received,

Read more »
Company cases

Biosergen: A big step

Biosergen has received approval for the next step in its phase 1 study of its drug against deadly fungal infections, which has blockbuster potential. Not

Read more »

Del indlægget på sociale media eller på email.